+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Oncology Drugs Market Research Reports

From
From
Carcinoid Syndrome - Pipeline Insight, 2025 - Product Thumbnail Image

Carcinoid Syndrome - Pipeline Insight, 2025

  • Report
  • April 2025
  • 40 Pages
  • Global
From
TGFb Inhibitors - Pipeline Insight, 2025 - Product Thumbnail Image

TGFb Inhibitors - Pipeline Insight, 2025

  • Report
  • April 2025
  • 60 Pages
  • Global
From
Anti-CD30 Therapies - Pipeline Insight, 2025 - Product Thumbnail Image

Anti-CD30 Therapies - Pipeline Insight, 2025

  • Report
  • April 2025
  • 60 Pages
  • Global
From
Anti-CD22 Therapies - Pipeline Insight, 2025 - Product Thumbnail Image

Anti-CD22 Therapies - Pipeline Insight, 2025

  • Report
  • April 2025
  • 60 Pages
  • Global
From
From
TIM-3 Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

TIM-3 Inhibitor - Pipeline Insight, 2025

  • Report
  • April 2025
  • 60 Pages
  • Global
From
Cytidine Deaminase Inhibitors (CDA) - Pipeline Insight, 2025 - Product Thumbnail Image

Cytidine Deaminase Inhibitors (CDA) - Pipeline Insight, 2025

  • Report
  • April 2025
  • 60 Pages
  • Global
From
CXCR4 Receptor Antagonists - Pipeline Insight, 2025 - Product Thumbnail Image

CXCR4 Receptor Antagonists - Pipeline Insight, 2025

  • Report
  • April 2025
  • 60 Pages
  • Global
From
Cell Wall Inhibitors - Pipeline Insight, 2025 - Product Thumbnail Image

Cell Wall Inhibitors - Pipeline Insight, 2025

  • Report
  • April 2025
  • 60 Pages
  • Global
From
From
Aminopeptidase Inhibitors - Pipeline Insight, 2025 - Product Thumbnail Image

Aminopeptidase Inhibitors - Pipeline Insight, 2025

  • Report
  • April 2025
  • 60 Pages
  • Global
From
From
TRAIL Receptor 2 Agonists - Pipeline Insight, 2025 - Product Thumbnail Image

TRAIL Receptor 2 Agonists - Pipeline Insight, 2025

  • Report
  • April 2025
  • 60 Pages
  • Global
From
ERBB 2 Receptor Antagonists - Pipeline Insight, 2025 - Product Thumbnail Image

ERBB 2 Receptor Antagonists - Pipeline Insight, 2025

  • Report
  • April 2025
  • 80 Pages
  • Global
From
CD33 Antigen Inhibitors - Pipeline Insight, 2025 - Product Thumbnail Image

CD33 Antigen Inhibitors - Pipeline Insight, 2025

  • Report
  • April 2025
  • 60 Pages
  • Global
From
From
Notch Receptor Antagonists - Pipeline Insight, 2025 - Product Thumbnail Image

Notch Receptor Antagonists - Pipeline Insight, 2025

  • Report
  • April 2025
  • 60 Pages
  • Global
From
From
Loading Indicator

The Oncology Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat cancer. These drugs are used to treat a variety of cancers, including breast, lung, and prostate cancer. Oncology drugs are typically administered intravenously or orally, and can be used in combination with other treatments such as radiation and chemotherapy. The Oncology Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Bristol-Myers Squibb, Merck & Co., Pfizer, Novartis, and Roche. These companies are constantly researching and developing new drugs to treat cancer, as well as improving existing treatments. Additionally, many smaller companies are also involved in the Oncology Drugs market, providing innovative treatments and therapies. Show Less Read more